2022年3期
Liver Research
PRACTICE GUIDELINE
REVIEW ARTICLES
ORIGINAL ARTICLES
- Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression☆
- Berberine enhances the anti-hepatocellular carcinoma effect of NK92-MI cells through inhibiting IFN-gamma-mediated PD-L1 expression☆
- Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer☆
- Efficacy and safety of low-dose rifampicin in patients with benign intrahepatic cholestasis☆
- The S267F variant of sodium taurocholate co-transporting polypeptide is strongly associated with resistance to chronic hepatitis B and high level of serum total bile acids☆
- Exhaled volatile organic compounds for cholangiocarcinoma diagnosis☆